Home › NDC Lookup › RxCUI directory › RxCUI 639543

Candesartan cilexetil 32 MG Oral Tablet [Atacand] — RxCUI 639543

Name: Candesartan cilexetil 32 MG Oral Tablet [Atacand] (RxCUI 639543)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 639543 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI639543

Official nameCandesartan cilexetil 32 MG Oral Tablet [Atacand]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAtacand 32 MG Oral Tablet

FDA products mapped4

Package NDCs mapped6

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Candesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Candesartan is mainly used to treat high blood pressure — in adults and even in children as young as 1 year old. It's also used in adults with heart failure to reduce the risk of s...
You can take candesartan with or without food — it doesn't affect how the drug works either way. As for timing, it's usually taken once a day, and the most important thing is to ta...
Does it matter what time of day I take it, or if I take it with food?
Most people tolerate candesartan well. You might notice some dizziness — especially when you first start or if your dose changes — along with occasional headache or a stuffy nose....

📖 Read our full Candesartan guide →

🕸️ Concept Web — How Candesartan cilexetil 32 MG Oral Tablet [Atacand... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Candesartan cilexetil 32 MG Oral Tablet [Atacand] RxCUI 639543 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Candesartan 214354 IN
- Candesartan cilexetil 135481 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Atacand 215458 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Candesartan Oral Tablet 371247 SCDF
- Candesartan cilexetil Oral Tablet 2648125 SCDFP
- Candesartan Oral Product 1156611 SCDG
- Candesartan Pill 1156612 SCDG
- Candesartan cilexetil Oral Product 2659944 SCDGP
- Candesartan cilexetil Pill 2661436 SCDGP
- Candesartan Oral Tablet [Atacand] 368268 SBDF
- Candesartan cilexetil Oral Tablet [Atacand] 2656912 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Candesartan cilexetil 32 MG Oral Tablet 639537 SCD
- Candesartan cilexetil 32 MG 577780 SCDC
- Candesartan cilexetil 32 MG [Atacand] 577782 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Candesartan cilexetil 32 MG Oral Tablet SCD · 639537
Candesartan cilexetil 32 MG SCDC · 577780
Candesartan Oral Tablet SCDF · 371247
Candesartan cilexetil Oral Tablet SCDFP · 2648125
Candesartan Oral Product SCDG · 1156611
Candesartan Pill SCDG · 1156612
Candesartan cilexetil Oral Product SCDGP · 2659944
Candesartan cilexetil Pill SCDGP · 2661436

Brand-Name Concepts

Candesartan cilexetil 32 MG [Atacand] SBDC · 577782
Candesartan Oral Tablet [Atacand] SBDF · 368268
Candesartan cilexetil Oral Tablet [Atacand] SBDFP · 2656912
Atacand Oral Product SBDG · 1172187
Atacand Pill SBDG · 1172188
Atacand BN · 215458

📦 FDA Products & Package NDCs

4 products · 6 package NDCs

6 package NDCs map to RxCUI 639543 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
62559-0640-30	30 TABLET in 1 BOTTLE (62559-640-30)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01
62559-0641-30	30 TABLET in 1 BOTTLE (62559-641-30)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01
62559-0642-30	30 TABLET in 1 BOTTLE (62559-642-30)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01
62559-0642-90	90 TABLET in 1 BOTTLE (62559-642-90)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01
62559-0643-30	30 TABLET in 1 BOTTLE (62559-643-30)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01
62559-0643-90	90 TABLET in 1 BOTTLE (62559-643-90)	ATACAND	ANI Pharmaceuticals, Inc.	2018-10-01

Observed labelers: ANI Pharmaceuticals, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.